Cargando…
Lacosamide Inhibition of Na(V)1.7 Channels Depends on its Interaction With the Voltage Sensor Domain and the Channel Pore
Lacosamide, developed as an anti-epileptic drug, has been used for the treatment of pain. Unlike typical anticonvulsants and local anesthetics which enhance fast-inactivation and bind within the pore of sodium channels, lacosamide enhances slow-inactivation of these channels, suggesting different bi...
Autores principales: | Labau, Julie I. R., Alsaloum, Matthew, Estacion, Mark, Tanaka, Brian, Dib-Hajj, Fadia B., Lauria, Giuseppe, Smeets, Hubert J. M., Faber, Catharina G., Dib-Hajj, Sulayman, Waxman, Stephen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724789/ https://www.ncbi.nlm.nih.gov/pubmed/34992539 http://dx.doi.org/10.3389/fphar.2021.791740 |
Ejemplares similares
-
Differential effect of lacosamide on Na(v)1.7 variants from responsive and non-responsive patients with small fibre neuropathy
por: Labau, Julie I R, et al.
Publicado: (2020) -
Effects of ranolazine on wild-type and mutant hNa(v)1.7 channels and on DRG neuron excitability
por: Estacion, Mark, et al.
Publicado: (2010) -
Contributions of Na(V)1.8 and Na(V)1.9 to excitability in human induced pluripotent stem-cell derived somatosensory neurons
por: Alsaloum, Matthew, et al.
Publicado: (2021) -
The fates of internalized Na(V)1.7 channels in sensory neurons: Retrograde cotransport with other ion channels, axon-specific recycling, and degradation
por: Higerd-Rusli, Grant P., et al.
Publicado: (2022) -
Paclitaxel increases axonal localization and vesicular trafficking of Na(v)1.7
por: Akin, Elizabeth J, et al.
Publicado: (2021)